Tampere University of Technology - Institute of Biomaterials

The Institute of Biomaterials is specialised in research and education of biotechnology and biomaterials.

The institute developed the world’s first bioabsorbable implant in 1984, and it is an internationally recognised pioneer in the development of bioreconstructive MCP joint prosthesis for patients suffering from rheumatoid arthritis.

Minna Kellomäki, Head of Institute

Hermiankatu 12 A
PL 589
33101 Tampere
Finland
Phone: +358-3-3115-2481
Fax: +358-3-3115 2250

The institute researches and develops biodegradable synthetic and natural polymers, their processing and applications, particularly for surgery, pharmacology, and tissue engineering.

The bioabsorbable prostheses developed by researchers of the institute are produced using a specially developed fibre, which retains its durability in the body until the patient’s own cells gradually replace the prosthesis within three to six months. Due to their porous structure, the patients’ cells can grow into the prosthesis and fill it. After a distinct period of time the fibre is hydrolised and absorbed into the body, forming a cell nutrient that further promotes cell growth.